ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A10AE54 | BioTech | Insulin glargine - 100IU/ml, Lixisenatide - 50mcg/ml | 10560 | 160320/1 | SULIQUA | 3x3ml | Injectable solution | SC | Mersaco | Sanofi Aventis Deutschland GmbH | Germany | 11,286,573 L.L | 21.26 | C | Sanofi Aventis (Suisse) SA | Switzerland | 12/12/20 | 0 |